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Abstract.  Agrin is a basal lamina protein that induces 
aggregation of acetylcholine receptors (AChRs) and 
other molecules at the developing neuromuscular junc- 
tion. Alternative splicing of chick agrin mRNA at two 
sites, A  and B, gives rise to eight possible isoforms of 
which five are expressed in vivo. Motor neurons ex- 
press high levels of isoforms with inserts at sites A 
and B, muscle cells synthesize isoforms that lack 
amino acids at the B-site.  To obtain further insights 
into the mechanism of agrin-induced AChR aggrega- 
tion, we have determined the ECs0 (effective concen- 
tration to induce half-maximal AChR clustering) of 
each agrin isoform and of truncation mutants. On 
chick myotubes, ECs0 of the COOH-terminal, 95-kD 
fragment of agrinA4a8 was ,'~35 pM, of agrinA4aZ9 ~110 
pM and of agrinA4a,  --5  nM.  While some AChR 
clusters were observed with 64 nM of agrinA4aO, no 
activity was detected for agrinAoa0. Recombinant full- 
length chick agrin and a  100-kD  fragment of ray agrin 
showed similar ECso values. A  45-kD,  COOH-terminal 
fragment of agrinA4u retained high activity (ECso ---- 
130 pM) and a 21-kD fragment was still active, but 
required higher concentrations (ECs0 ---  13 nM).  Un- 
like the 45-kD fragment, the 21-kD fragment neither 
bound to heparin nor did heparin inhibit its capability 
to induce AChR aggregation. These data show quan- 
titatively that agrinA4nS and agrinA4mg, expressed in mo- 
tor neurons, are most active, while no activity is de- 
tected in agrinAoBo, the dominant isoform synthesized 
by muscle cells. Furthermore, our results show that a 
fragment comprising site Bs and the most COOH- 
terminal G-like domain is sufficient for this activity, 
and that agrin domains required for binding to heparin 
and those for AChR aggregation are distinct from each 
other. 
T 
HE formation of chemical synapses in the nervous sys- 
tem requires exchange of local signals between pre- 
and postsynaptic cells. At the neuromuscular junction 
(NMJ) ~,  muscle cells  aggregate several proteins,  such as 
acetylcholine receptors (AChRs),  acetylcholinesterase, and 
heparan sulfate proteoglycans at the site of contact between 
nerve and muscle cell. This process is, at least in part, initi- 
ated by the release of molecules from the motor axon. Sev- 
eral lines of evidence suggest that agrin,  a  component of 
synaptic basal lamina, is such a molecule. On cultured myo- 
tubes, agrin induces aggregation of several  molecules that 
are concentrated at the NMJ including AChRs (Nitkin et al., 
1987;  Wallace,  1989).  Motor  neurons  synthesize agrin, 
transport it to the nerve terminal from where it is released 
to induce AChR aggregation (Magill-Solc and McMahan, 
1988, 1990;  Reist et al.,  1992; Cohen and Godfrey, 1992). 
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cDNAs encoding agrin have been cloned in rat, chick, and 
the marine ray (Rupp et al., 1991; Tsim et al., 1992; Smith 
et al., 1992).  The deduced protein from full-length cDNAs 
of rat and chick has a calculated Mr of more than 200 kD. 
It contains several domains that are homologous to motifs 
found in other proteins of the extracellular matrix. Within 
the COOH-terminal half of agrin, two sites are altered as a 
result of alternative mRNA splicing (Ruegg  et al.,  1992; 
Rupp et al., 1992). In chick, the sites are referred to as site 
A and site B (Ruegg et al., 1992); the same sites in rat are 
called y and z (Hoch et al., 1993).  Site A encodes 4 amino 
acids and site B codes for either 8,  11, or 19 (8 +  11) amino 
acids. By PCR techniques, it has been shown in chick,and 
rat that isoforms containing inserts at the B-site always carry 
inserts at the A-site (Ruegg et al., 1992; Hoch et al., 1993). 
Thus, alternative mRNA splicing at the two sites is coordi- 
nated and thereby the number of agrin transcripts expressed 
in vivo, that differ at sites A and B, is restricted to five. In 
this report we refer to the isoforms encoded by these tran- 
scripts  as  agrin~oao, agrinA4B0, agrinA4ss, agrin^4B,, and 
agrinA4B,9. Alternatively spliced mRNAs are expressed tis- 
sue specifically and depend upon the developmental stage. 
Single cholinergic neurons of chick ciliary ganglia contain 
mixtures of mRNAs encoding Bo, Bs, B.,  and B19 inserts. 
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ment, nevertheless the most abundant mRNA at embryonic 
days 6-20 encodes agrin^4B19 (Smith and O'Dowd, 1994). At 
embryonic days 5 and 6, chick motor neurons also express 
high levels of agrin^4m9 (Ruegg, M. A., M. J. Werle, S. E. 
Horton,  L.  S.  Honig,  and U. J.  McMahan,  manuscript  in 
preparation).  Transcript specific in situ hybridizations indi- 
cated that, later in development, agrin^4m9  mRNA is down- 
regulated and mRNA for agrin^4~  becomes most abundant 
in motor columns (Honig, L. S., D. Stone, K. Nikolics, and 
U. J. McMahan.  1993.  Soc. Neurosci. Abstr. 1272). Thus, 
cholinergic  neurons  express  a  mixture  of agrin  isoforms 
and depending  on  the  developmental  stage,  agrin^4,s  or 
agrin^,B19 is most abundant.  Nonneuronal and muscle ceils, 
on the other hand,  express only mRNA encoding agrin^4B0 
and agrinmB0 (Ruegg et al.,  1992; Hoch et al.,  1993; Ma et 
al.,  1994; Smith and O'Dowd,  1994). 
The COOH-terminal half of agrin^4BH is sufficient to in- 
duce AChR clustering on cultured primary myotubes and this 
activity  is  indistinguishable  from  that  of purified  Torpedo 
agrin (Tsim et al.,  1992). When tested in a qualitative way, 
this activity was dependent on the presence of amino acids 
at both sites A and B (Ruegg et al.,  1992). Similarly, AChR- 
aggregating activity of rat agrin differs between isoforrns, al- 
though the extent of the changes in activity depended on the 
experimental conditions,  such as the origin of muscle cells 
and the size of rat agrin  (Ferns et al.,  1992,  1993). 
Several lines of evidence suggest that agrin binds to recep- 
tors  on  the  muscle  cell  surface  and  that  aggregation  of 
AChRs is mediated by an intracellular cascade. Before aggre- 
gation the/3  subunit of the AChR becomes tyrosine phos- 
phorylated  (Wallace  et  al.,  1991).  Staurosporine,  a  non- 
selective antagonist  of protein  kinases,  blocks both phos- 
phorylation of the/~ subunit and AChR aggregation (Wallace, 
1994), supporting the view that phosphorylation and aggre- 
gation of AChRs are causally linked. 
Evidence for an agrin-binding  site on muscle cells has 
been published by Nastuk et al. (1991). This binding protein 
has  been  characterized  biochemically  from  postsynaptic 
membranes of the electric organ of Torpedo californica (Ma 
et al.,  1993; Bowe et al.,  1994). Peptides derived from this 
binding  protein  are highly  homologous to ct-dystroglycan 
(Bowe et al.,  1994). Indeed, recent experiments have shown 
that an ,,d00-kD fragment of rat agrin binds specifically to 
this peripheral membrane protein on muscle cells. Its bind- 
ing  is  Ca2+-dependent  and  is  inhibited  by low concentra- 
tions of heparin (Campanelli et al.,  1994; Gee et al.,  1994; 
Sugiyama et al.,  1994).  a-Dystroglycan is a component of 
the dystrophin-glycoprotein complex, which forms, via dys- 
trophin,  a  network with  the  cytoskeleton.  Earlier  studies 
showing that laminin binds to ot-dystroglycan (Ibraghimov- 
Beskrovnaya et  al.,  1992)  suggested  that  the  dystrophin- 
glycoprotein complex links basal lamina and cytoskeleton of 
muscle cells to confer physical stability of the sarcolemma 
and to guarantee maintenance of calcium homeostasis dur- 
ing  contractions  (for a  recent review  see Matsumura  and 
Campbell,  1994).  The  finding  that  agrin  binds to ot-dys- 
troglycan has suggested that this protein complex may also 
be important for the formation of the NMJ. A question that 
remains is whether binding of o~-dystroglycan induces the in- 
tracellular  signaling  cascade  that  triggers  aggregation  of 
AChRs on cultured muscle cells (see also Sealock and Froeh- 
ner,  1994; Sugiyama et al.,  1994). 
The aim of our work was (a) to determine quantitatively 
the activities of agrin isoforms synthesized by neurons and 
by nonneuronal ceils and (b) to establish how individual do- 
mains of agrin contribute to its AChR-aggregating  activity. 
Our results show that agrin isoforms with the 8-amino acid 
insert at site B are most active, while absence of amino acids 
at this site lowers the activity by more than three orders of 
magnitude.  Furthermore,  we show that a COOH-terminal, 
21-kD fragment of agrin is sufficient for this activity. AChR 
aggregation  induced  by this  fragment  is  not  inhibited  by 
heparin.  Hence, the heparin-binding  site of agrin is not re- 
quired to activate the signal-transducing  receptor. 
Materials and Methods 
Polymerase Chain Reaction and Oligonucleotides 
Conditions for PCR were as follows: 20 mM Tris-HC1 (pH 8.4), 50 mM 
KCI, 2.5 mM MgCI2, 0.2 mM of each dNTP, 50 pmol of each primer and 
2.5 U ofTaq polymerase (GIBCO BRL, Galthersburg, MD). Reaction vol- 
ume was usually I00 pl. Numbering of  oligonucleotides is according to the 
sequences published by Tsim et al. (1992) and Smith et al. (1992). All PCR 
products used to generate expression constructs were cloned into PCR 1000 
or PCR II cloning vectors (Invitrogen, San Diego, CA) and sequenced to 
ensure that no mutations were introduced by DNA amplification. To distin- 
guish expression constructs and recombinant protein, cDNA constructs are 
named with the prefix p followed by the name of the recombinant protein 
they encode. 
Identification  of SpUce Variants in Chick and the 
Marine Ray 
Reverse transcriptase-polymerase  chain  reaction  was conducted  as  de- 
scribed in Ruegg et al. (1992). For chick, poly (A)  + RNA from embryonic 
day 10 dorsal root ganglia served as a template, while for the marine ray, 
mRNA isolated from electric lobe of adult Discopyge  ommata  was used. 
Oligonucleotides used for chick were s5381 (TTT COT GGT AGG ACG 
TAC AT) and as5491 (CTT CTG TTT TCJA TGC ~  GC); for the marine 
ray s3451 (GC~ CGC ACA TIC ATT GAG TAT CAC) and as3511 (TTC 
AAA ATA ATT AAC TTG T). PCR products were cloned into PCR 1000 
(Invitrogen) and sequenced using Sequenase 2.0 (USB, Cleveland, OH). 
The chick sequence of Bi9 was identical to that submitted to the GenBank 
by Thomas et al.  (1993). The protein sequence for Bs of Discopyge om- 
mata has been published by McMahan et al. (1992). Nucleotide sequence 
data are available from EMBL/GenBank/DDBJ under accession number 
U16146. 
Expression Constructs 
Constructs Encoding the 95-kD Fragment of  Chick Agrin.  All agrin con- 
structs used in this work contain an artificial ER signal sequence derived 
from hemngglutinin of the avian influenza virus described by Tsim et al. 
(1992). This signal sequence was inserted into the expression vector pcDNAI 
(Invitrogen). 
The constructs encoding the COOH-terminal half of chick agrin (c95) 
are based on ARP-2coN^ (Ruegg et al., 1992). Pc95^4Bn was generated as 
previously reported (Ruegg et al., 1992). The insert for pc95^4at9 was ob- 
tained by fusion of overlapping DNA fragments derived from CBA-I (Tsim 
et al.,  1992) and the cloned PCR product encoding the BI9 isoform (see 
above).  The  fused  DNA  fragment,  spanning nucleotides 5023-5827  in 
chick agrin, was cloned into PCR 1000 (Invitrogen) and a eDNA fragment 
with the BI9 site was excised by XhoI and ApaI restriction endonucleases 
and  was inserted  into pc95^4an  as previously described  (Ruegg et al., 
1992). PC95A4a8 was obtained  by fusing overlapping PCR products.  To 
achieve this,  a Xhol-ApaI restriction  fragment of pc95Aoa0 was inserted 
into Bluescript vector  KS  + (Stratagene Corp., La JoHa, CA).  PCR was 
performed using T3 as a sense primer (ATT AAC CCT CAC TAA AGG 
GA) and the antisense primer as5408  B8 (GGG ATC ~  TTG CTC AGG 
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using T7 primer (TAP, TAC GAC TCA CTA TAG GG) and the sense oligo- 
nucleotide B8  s5457 (ACC TGA GCA ATG AGA TCC CTG CCG AGA 
AGG CTT IV_JC AAT CC). After isolation from agarose gel, the two frag- 
ments were fused by PCR amplification in the presence of T3  and T7 
primer. The PCR product was purified, cut with XhoI and Apal restric- 
tion endonncleases, and exchanged with the corresponding fragment in 
pC95A4aU. PC95A4aO was  made  by  replacing  a  ClaI-XbaI  fragment of 
pc95A4m9  with  the  corresponding  fragment  obtained  from  ClaI-XbaI 
digestion of ARP-lct~NA (Ruegg et al.,  1992). 
Construction  of Full-Length  Chick Agrin.  eDNA clones PE-3 and 
PE-1 that encode the 5' end of chick agrin (Tsim et al., 1992) were joined 
by PCR: Amplification was conducted on PE-3 with s6 (CCT TAA TCT 
O'I'G ACA AC) and as934  (CCA CCG CTT  CAG GCA GAC AGC) as 
primers, and on PE-1  with s903  (GGA CAA ATG CAA GGA "I13) and 
as1662 (GGC AGG AGG CTG CTC GG) as primers. Both PCR products 
were gel purified and fused by DNA amplification using primers s6 and 
as1662.  The resulting PCR products were inserted into PCR 1000  vector 
(Invitrogen) and several clones were sequenced. One clone with no muta- 
tions was joined with PE-1 by restriction digestion with ApaI and ligation 
with the insert of PE-1, cut with ApaI. The resulting insert in PCR 1000 
comprised agrin sequences from nucleotide 6-3690.  This clone was subse- 
quently digested with BamHl and ligated to CBA-1 (Tsim et al., 1992) that 
had been cut with the same restriction endonuclease. Clones were screened 
for the correct orientation and the insert comprising full-length chick agrin 
was moved into the expression vector pcDNAI by excision with EcoRl. 
To facilitate work with this expression construct the BamHi restriction 
site, located in the polylinker at the 5' end of full-length agrin, and the 
EcoRI-site at the 3' end were both destroyed by restriction digest with the 
corresponding endonuclease, followed by filling recessed ends by treatment 
with Klenow polymerase and religation. This led to a  full-length cDNA 
construct (pCA) with a unique EcoRI site at its 5' end and a unique XbaI 
site at its 3' end. Exchange of the endogenous, putative signal sequence with 
the hemagglutinin signal sequence was achieved as follows: PCR was con- 
ducted onpCA and primers EcoRI  s193 (AGC TTG AAT TCG AAG CCC 
AAT AGC TAT TTT ACC CAG) and as1036 (TTT CTG CCG CTC ACA 
GTC ATT).  The resulting PCR product was gel purified, digested with 
EcoRI and BssHII, and inserted into the EcoRI/BssHII cut pCA. Fusion 
to the artificial signal sequence was completed by cutting the PCR-modified, 
full-length eDNA with EcoRI and Xbal restriction enzymes and iigating the 
insert  into  pcDNAI  containing  the  signal  sequence  giving  rise  to 
pcFullA4aU.  Constructs with different B-sites were generated by exchang- 
ing ClaI-SmaI restriction fragments isolated from the corresponding  pc95- 
constructs. PcFullA0a0 was obtained by replacing the BamHI-XbaI frag- 
ment in pcFullA4m i with the corresponding fragment of ARP-2cDNA (Ruegg 
et al.,  1992). 
Constructs Encoding  43 kD and 21 kD Fragments.  /~,45  constructs 
were generated by PCR using pC95A4BS as template together with the oligo- 
nucleotides EcoRI  s4648 (AGC TTG AAT TCG GAG CAG GAC CAC 
ACC A) and an antisense primer corresponding to the nncleotide sequence 
of Ba,  as-B8 (GCA GGG ATC  TCA TTG  CTC  AGG TGG),  The  PCR 
product was gel purified, digested with EcoRI and Clal, and inserted into 
pcFulIA4BS or pcFuilA0a0, respectively. Pc21Bs and pc21a0 were generated 
by  PCR  using  pCaSA4BS and  pc45A0a0  as  templates  together  with 
EcoR/  s5351  (AGC TTG AAT TCA GCT GGA GAT GCA GAG G) and 
as6146  XbaI (CCG GGT CTA GAC TTG GTT CAA GGT TT).  PCR 
products were purified from agarose gels and digested with EcoRI and 
XbaI.  After  isolation  from  agarose  gels,  fragments  were  ligated  into 
EcoRI-Xbal cut pcDNAI expression vector containing the signal sequence. 
The complete coding region was sequenced in order to verify the PCR 
fragment. 
Constructs Encoding 100 kD Fragment of the Marine Ray.  To gener- 
ate  an  expression  construct,  the  partial  cDNA  clone  OL4  encoding 
agrinA4a0 of Discopyge ommata (Smith et al.,  1992)  served as template. 
cDNA was digested with NarI and recessed ends were filled with Klenow 
polymerase.  After  digestion  with  XbaI  restriction  endonuclease  and 
purification on agarose gel, the fragment was inserted into pcDNAI contain- 
ing the signal sequence that had been cut with EcoRI, filled with Klenow 
polymerase and redigested with XbaI.  This procedure yielded prl00a4aO 
encoding recombinant agrinA4aO that is 35 amino acids longer than the 95- 
kD fragment isolated from basal lamina extracts of the electric organ of 
Torpedo californica (for NH2 terminus of the 95-kD fragment, see Smith 
et al.,  1992).  To generate prl00A4Bs, prl00A,m0 was digested with HindlII 
restriction endonnclease and inserted into HindlII-cut PeDNAI.  A  first 
PCR was performed on this construct with T7 and as3479  B8 (TGG GAT 
CTC ATT "IVJC  AAG ATG GCT CCT TGT CAC TGT GTT GT) as primers. 
A second PCR on the same template used SP6 (CAT TTA GGT GAC ACT 
ATA G) and B8  s3498 (ATC TTG CAA ATG AGA TCC CAG ATG AGA 
AAG CTG TAC AAG TT) as primers. After purification, the two products 
were fused in a third amplification using primers 1"7 and SP6.  The PCR 
product was cloned into PCR II vector (Invitrogen), digested with both 
Eco47III and SphI, and the resulting DNA fragment was exchanged with 
the corresponding fragment ofprl00A4a0. 
Tissue Cultures 
Chick Myotube Cultures.  Myotube cultures were prepared from hind limb 
muscles of ll-12-d White Leghorn chick embryos by the method of Fisch- 
bach (1972).  Modifications of  these procedures were as follows: freshly dis- 
sociated myoblasts were plated in a density of ",,1.5  ×  105 cells onto 35- 
mm plastic tissue culture dishes previously coated with 0.3  nag gelatin 
(Sigma Chem. Co., St. Louis, MO). Growth medium consisted of MEM 
(G1BCO BRL) supplemented with 10%  horse serum (GIBCO BRL), 4% 
chick embryo extract (prepared from I 1-d-old chick embryos with an equal 
volume of Puck's saline G [Puck et al., 1958]),  100 U/ml penicillin (GIBCO 
BRL) and  100/~g/ml  streptomycin (GIBCO BRL).  After 2.5 d,  growth 
medium  was  replaced  by  differentiation medium  consisting of growth 
medium with only 2% chick embryo extract and 0.5  x  10 -5 M cytosine 
arabinoside (Sigma Chem. Co.). Cultures were used 3.5-4.5 d after plating. 
C2C12 Cell Line.  C2C12  cells were proliferated in DME containing 
10% horse serum (GIBCO BRL), 10% newborn caif serum, 100 U/ml peni- 
cillin, and 100/~g/ml streptomycin. Approximately 0.5  x  105 cells were 
plated on gelatin-coated 35-mm tissue culture dishes and after one day, 
medium was replaced with DME containing 2% FCS (GIBCO BRL), 100 
U/mi penicillin, and 100 ~g/ml streptomycin. After 4-6 d, cells had fused 
and AChR aggregation assays were performed. 
Transfection  and Culturing  of COS-7 and 293 Cells.  COS-7 (Gluz- 
mann,  1981) and 293 (Graham et al.,  1977) cells were cultured in DME 
(GIBCO BRL) supplemented with 10%  newborn calf serum,  10 mM so- 
dium pyruvate, 100 U/ml penicillin, and 100 mg/ml streptomycin (all from 
GIBCO BRL). COS-'/cells were transiently transfected with the DEAE- 
dextran-based method described by Cullen (1987).  293 cells were trans- 
fected by the method described by Gorman et al. (1990).  Supernatants were 
usually collected 3 d after transfection. 
To establish stably transfected cell lines, 293 cells that had been plated 
onto a 100-mm tissue culture dish at 70% confluence were transfected with 
agrin constructs together with 1/10 of a helper plasmid (pRSV-Tneo; Got- 
man et al. [1990]) that carried a neomycin resistance gene. One day after 
transfection, cells were plated onto two or three 100-mm culture dishes and 
600/zg/ml (3418 (GIBCO BRL) was added to the medium. After 2-3 wk, 
individual colonies were picked and stained intracellularly with mAb 5B1 
or the polyclonal anti-agrin antiserum. Colonies expressing high levels of 
recombinant agrin were cloned by limited dilution into 96-well plates. Posi- 
tive clones were selected and grown in medium without G418. 
Quantification of  AChR Aggregation 
Chick muscle cells or C2C12 myotubes were incubated with agrin for 16 h 
at 37°C. In experiments where the effect of heparin (grade I, Sigma Chem. 
Co.) on AChR aggregation was measured, muscle cells were exposed to 
agrin  for only 6  h  under  serum-free conditions as described (Wallace, 
1988).  Cells  were then  rinsed with DME-F12  (Sigma),  1 mg/ml  BSA 
(Fluka, Buchs, Switzerland), and incubated in the same medium containing 
4  ×  10 -s M rhodamine-t~-bungamtoxin (Molecular Probes, Eugene, OR) 
for 45-60  min at 37°C.  Cultures were washed twice with DME-F12,  1 
mg/ml BSA followed by one rinse with MEM. They were fixed with 95 % 
ethanol for 5 min at  -20"C and mounted on glass coverslips with 90% 
glycerol, 10% PBS. Cultures were examined at a magnification of 400x on 
a microscope equipped with epifluorescence (AH-2; Olympus Optical Co., 
Tokyo, Japan). To determine the extent of AChR clustering, segments of 
healthy myotubes were chosen under phase optics, and both phase and 
rhodamine optics were imaged with a SIT-camera (model 66; Dage-MTI, 
Michigan City, IN) that was connected to an imaging system (Image-l/AT; 
Universal Imaging, West Chester, PA). The threshold of the digitized im- 
ages was set by eye such that AChR aggregates were clearly distinct from 
background labeling of myotubes. The threshold was kept constant through- 
out the analysis of  one series of  experiments. Myotubes were outlined manu- 
ally and AChR aggregates (i.e.,  objects above threshold) were counted 
within the outlined area. Only AChR aggregates with a longer axis of at least 
4  ~m were included in the counting. For chick myotubes, data were ex- 
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100 t~m) of a myotube segment. Because of the shape of AChR aggregates 
on C2C12 cells, the ratio of areas occupied by AChR aggregates to total 
area of the myotube segment proved to be more accurate as a measure of 
agrin's activity. In each 35-mm culture dish,  10 individual myotube seg- 
ments were counted. Pictures taken in phase optics were used to exclude 
non-specifically labeled cell debris. 
Antibodies 
mAb 5B1 (Reist et al., 1987) was a kind gift of Dr. U. J. McMahan (Depart- 
ment of Neurobiology, Stanford University School of Medicine, CA). To 
purify IgGs, hybridomas were grown in DME containing 10% IgG-depleted 
FCS (GIBCO BRL). Conditioned medium was buffered with 20 mM Hepes 
(pH 7.2) and applied to protein G-Superose (Pharmacia, Uppsala, Sweden). 
After washing with 20 mM sodium phosphate, pH 7.0, IgGs were eluted 
with 100 mM glycine-buffer (pH 2.7) and immediately neutralized by add- 
ing 1/10 vol of 1 M Tris-HCl (pH 7.0).  Polyclonal antisera were raised in 
two rabbits by injecting immunoaflinity-purified C95A4aU. For the first in- 
jection '~,60 #g of protein in complete Fround's adjuvant were used. For 
booster injections in 4-8-wk intervals, the same amount of C95A4m~ was 
dissolved in incomplete Freund's adjuvant. Titer of anti-c95A4ml IgG in the 
sera was determined by immunoprecipitation of agrin-containing medium 
of stably transfected 293  cells and by staining cryostat-sections of em- 
bryonic day  18 chick pectoral muscle. 
Purification of Recombinant Agrin.  mAbs 5B1  were covalently cou- 
pled  to  Afli-10  beads  (BioRad  Labs,  Hercules,  CA)  according  to  the 
manufacturer's  instruction.  Conditioned  media  of transiently  or  stably 
transfected cells was loaded onto the column with a flow rate of '~20 ml/h. 
The column was washed sequentially with 20 vol each of 50 mM Tris buffer, 
pH 7.5, containing 150 mM NaC1, 5% glycerol, 0.5% Triton X-100;  Tris 
buffer containing 1 M NaCl, 5% glycerol and 0.5% Triton X-100 and Tris 
buffer containing 150 mM NaCI and 5% glycerol. Columns were eluted 
with 10 vol of 50 mM triethylamine, pH  11.5, containing 150 mM NaCI 
and  5%  glycerol.  Fractions  (1.5 ml)  were  collected and  immediately 
buffered with 180 #1 of 1 M Tris-HCl, pH 7. Aliquots of each fraction were 
analyzed on 7.5% SDS-PAGE and proteins were visualized by silver stain- 
ing (Morrisey,  1981). Fractions with high concentrations of agrin were 
pooled and dialyzed three times against 1.5 liter of PBS. Centricon-30 con- 
centrators (Amicon Corp., Danvers, MA) were used to concentrate agrin. 
Agrin concentration was determined according to Lowry et al. (1951) using 
the DC Protein assay kit (BioRad Labs) and BSA as a standard. As an inde- 
pendent measure, the relative intensity of agrin on silver-stained gels was 
estimated by dilution series of known amounts of bovine serum albumin. 
Highly pure fractions with known concentrations of agrin were used as in- 
ternal standards in the ELISA. 
Agrin Binding to Heparin Columns.  2 ml of heparin (type II)-agarose 
beads (Sigma Chem. Co.) were used as heparin affinity columns. 2.5 ml 
of 35S-labeled conditioned media from COS cells transfected with pC45A41~S 
or pC21BS were loaded onto separate heparin columns.  Bound proteins 
were eluted with 2.5 ml of 50 mM Tris-HCl, pH 7.5, containing 500 mM 
NaCI, and 5% glycerol. Aliquots of the flow through and the eluate were 
immunoprecipitated as described below. 
Quantification of Agrin 
ELISA.  ELISA was essentially done as described by Ruegg et al. (1989) 
with the following modifications: mAb 5B1 (10/~g/ml)  was immobilized on 
microtiter plates followed by incubation of c95 proteins at a concentration 
between 0.5 and 10 ng/ml. As a secondary antibody, purified rabbit anti- 
C95A4B, IgG at a concentration of 5.6 ~g/ml was used. To eliminate cross- 
reactivity of IgG with 5B1, antiserum was always  preadsorbed with 5B1 
beads. The third antibody, a  peroxidase-conjngated goat anti-rabbit IgG 
(BioRad Labs) was used in a  1:2,000  dilution. The detection limit of this 
procedure was ,050 pg of agrin. As an internal standard, purified recom- 
binant c95 protein with known concentration (see above) was used. 
Metabolic Labeling, Imraunoprecipitation, and Quantification. Inde- 
pendent of ELISA,  concentrations of recombinant agrin  in conditioned 
medium oftransfected  cells was determined as follows: six hours after trans- 
fection, medium was changed to 25% DME, 65% MEM without methio- 
nine,  10%  IgG-depleted FCS  (all  from GIBCO  BRL)  and  50  btCi/ml 
[35S]methionine  (Du Pont, Bad Homburg, Germany). Cells were grown in 
this medium for 2.5 d. Except for c45 and c21-contalning medium, aliquots 
were  removed  for  independent measure  of the  agrin  concentration by 
ELISA.  Aliquots  used  for  immunoprecipitations  were  300  /~1  (c95- 
fragments) and 30/zl (c45- and c21 proteins). Volumes were adjusted to 1 
ml with a 50- mM Tris-HCl buffer, pH 7.5, containing 5% glycerol and 150 
mM NaCI and 10 #1 of rabbit anti-grin antisera was added. After incuba- 
tion for 3 h at 4°C, 60/~1 of a 30% suspension of  protein A-Sepharose (Phar- 
macia) in 0.14 M sodium phosphate, pH 8.3, was added and incubation was 
continued for an additional 90 min. Supernatant was removed and subjected 
to a second immunoprecipitation to guarantee that agrin had been depleted 
in the first round by at least 90%. The beads were then washed sequentially 
as described for immunoatlinity columns, except that NaCI was raised only 
to 625 mM. Bound antigen-antibody complexes were released by boiling 
for 5 min in 60/zl of SDS-PAGE sample buffer (Laemmli, 1970).  Samples 
were separated by SDS-PAGE on a 3-12% gradient gel. Gels were dried 
and  the  amount  of  [35S]  incorporated  into  recombinant  agrin  was 
quantified by volume integration with a Phosphorlmager (Molecular Dy- 
namics, Sunnyvale, CA). To calculate the molar amount of different agrin 
fragments, the radioactivity incorporated was corrected with the number of 
methionines present in different agrin fragments. Concentrations of c45 and 
c21 in conditioned medium was determined by comparison of incorporated 
radioactivity with that of immunoprecipitated C95A4BS, whose concentra- 
tion had also been determined by ELISA. 
Results 
cDNA Constructs, Heterologous Expression, and 
AChR-clustering Activity of  Agrin Isoforms 
Most studies of the molecular mechanisms of agrin-induced 
AChR aggregation and of the binding properties of agrin 
have used purified protein from the electric organ of Torpedo 
californica (e.g., Wallace, 1988, 1989; Wallace et al., 1991; 
Ma  et  al.,  1993).  The  main  protein  containing  AChR- 
aggregating activity in these fractions has an apparent Mr of 
95 kD (Nitkin et al.,  1987).  To compare activities of agrin 
isoforms with previous results, we used ARP-2cDNA (Ruegg 
et al.,  1992) as a template. The protein encoded by ARP- 
2eDNA is expected to have the same size as the 95-kD protein 
from Torpedo californica. We also tested whether regions in 
the NH2-terminal  half of full-length agrin would affect ac- 
tivity by generating cDNA constructs that encode the com- 
plete amino acid sequence of the mature chick agrin protein 
(Tsim et al., 1992). Finally, we generated constructs encod- 
ing recombinant agrinA4B0 and agrinA4Bs of the electric ray, 
Discopyge ommata, to compare activity of agrin isoforms 
from different species.  The structure of recombinant agrin 
fragments and their nomenclature is shown in Fig.  1. 
Recombinant protein was obtained by transfecting cDNA 
constructs into COS-7  (Gluzman, 1981) or 293  cells (Gra- 
ham et al.,  1977).  Recombinant agrin in the conditioned 
medium was identified by immunoprecipitation with mAb 
5B1  (Reist et al.,  1987)  or a  polyclonal antiserum raised 
against recombinant c95A4mt. Fig. 2 shows a fluorogram of 
the recombinant proteins that had been resolved by SDS- 
PAGE. The apparent Mr of '~95 kD of recombinant chick 
c95  proteins  fits  well  with  the  predictions  from protein 
purified from Torpedo californica. Recombinant agrin en- 
coded by the ray cDNA,  rl00A,as, has an apparent Mr of 
~100 kD,  which is expected because it is 44 amino acids 
longer than the corresponding c95-isoform in chick (Fig. 2). 
Recombinant full-length chick agrin, whose putative signal 
sequence  had  been  replaced  by  the  signal  sequence  of 
hemagglutinin of the influenza virus, is secreted efficiently 
by COS and 293 cells. It migrates on SDS-PAGE as a broad 
smear  with  an  apparent  Mr  of  400-600  kD  (Fig.  2). 
Deglycosylation experiments with heparitinase,  chondroi- 
tinase ABC, and keratanase indicate that recombinant chick 
agrin is a heparan sulfate proteoglycan (Denzer, A. J., M. 
Gesemann,  and M.  A.  Ruegg,  unpublished observation). 
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of chick agrin and of recom- 
binant fragments used in this 
study. Domains, potential sites 
for  N-glycosylation and  gly- 
cosaminoglycan side chain at- 
tachment, and location of sites 
A and B including amino acid 
sequences are shown. Names 
of agrin  fragments are  indi- 
cated. 
Consistent with this observation,  several potential glycos- 
aminoglycan side chain  attachment  sites  (Bourdon et al., 
1987) are found in agrin and the positions of some of these 
sites are conserved in chick, rat, and electric ray (see Fig. 
1). The possibility that agrin exists in vivo as heparan sulfate 
proteoglycan is substantiated by the findings of Hagen et al. 
(1993),  who  characterized  heparan  sulfate  proteoglycans 
from bovine renal basement membranes. Two tryptic pep- 
tides from a purified proteoglycan are highly homologous to 
rat and chick agrin, suggesting that, at least in kidney, agrin 
may be a heparan sulfate proteoglycan. 
To measure the concentration of recombinant agrin in the 
conditioned medium of transfected cells, we established an 
ELISA  using  mAb  5B1  and  polyclonal  anti-c95^4en  an- 
tisera. The accuracy of this method was tested by comparing 
the results from the ELISA with those obtained by immuno- 
precipitation  of 35S-agrin.  As  shown  in  Table I,  the  two 
methods yielded the same results for chick agrin isoforms ir- 
respective of their size. The concentration of rl00^4Bs deter- 
mined by ELISA was only 60 % of that obtained by immuno- 
precipitation, which is most likely due to the lower avidity 
of the anti-c95A4B, antiserum to ray agrin. Thus, the ELISA 
is  a  valuable  tool  for  determining  the  concentration  of 
recombinant  agrin  in  conditioned medium  of transfected 
cells. Consequently, this method was used in the subsequent 
experiments. 
First, we tested the effect of different agrin isoforms on the 
maximal number, size, and shape of AChR aggregates by in- 
cubating cultured chick myotubes for 16 h  with excess of 
recombinant protein. AChRs were visualized using rhoda- 
mine-labeled  t~-bungarotoxin.  As  a  control,  conditioned 
medium of mock-transfected COS cells was added (Fig. 3 a). 
No AChR clustering was detected with 64 nM C95AOB0 (Fig. 
3 b), while some activity was observed with this high con- 
centration of C95A4B0 (Fig.  3 C).  On the other hand, AChR 
aggregates  were  induced  by  C95A4Bjl (Fig.  3  d),  C95A4m9 
Figure 2. Autoradiogram of recombinant agrin fragments. Recom- 
binant asS-agrin from transiently transfected COS-7 cells was im- 
munoprecipitated  by  anti-agrin  antiserum  and  separated  on  a 
3-12% SDS-polyacrylamide gel. Names of the recombinant pro- 
teins are according to Fig. 1. Molecular weight of standard proteins 
used are shown. Note the apparent Mr of cFUIIA4BS indicating its 
high content of carbohydrates. 
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Recombinant Agrin Determined by ELISA and 
lmmunoprecipitation 
Relative amount determined by 
Protein  ELISA  Immunoprecipitation 
mean  +  SEM  mean  5:  SEM 
C95A4BIg*  89.8  +  4.5  97.3  ±  2.6 
C95A4BII  100  100 
C95A*BS*  26.2  +  1.3  27.7  ±  2.1 
rl0OA4BS**  7.0  ±  0.6  11.5  +  0.2 
cFulIA4aS*  116.7  +  10.1  103.9  ±  4.0 
Relative amount of agrin in conditioned medium of COS cells that expressed 
the indicated fragments,  was determined by ELISA and immunoprecipitation 
with anti-agrin antiserum. Incorporated radioactivity was determined by a Phos- 
phorlmager as described in Materials and Methods. The number of methionine- 
residues in the recombinant protein were used to calculate the amount for each 
fragment. Values are means +  SEM of three independent experiments. Amount 
determined for c95^4B, was set to 100%. Both methods give the same results 
for all chick fragments, while for ray agrin, ELISA detects only '~60% of the 
concentration determined by immunoprecipitation. 
*, No significant difference between both methods (p > 0.1). 
*% Significant difference (p < 0.01). 
(Fig.  3  e),  and  C95A4Bg (Fig.  3  f).  Recombinant  chick 
cFuI1A4B8  and ray rl00A,Bg were also active (Fig. 3, g and h). 
The maximal number, sizes, and shapes of AChR aggregates 
induced by the active agrin isoforms were the same (Fig. 3, 
d-h).  Thus,  the amino acid composition of site  B  and the 
length of chick agrin as well as species differences between 
chick and ray do not affect the extent of AChR aggregation 
and the appearance  of the clusters. 
We next determined dose response curves for the COOH- 
terminal, 95-kD fragments of each chick agrin isoform. The 
number of AChR aggregates per myotube induced by differ- 
ent  concentrations  of recombinant  protein  was  measured 
with a computerized image analysis system.  Spontaneously 
20 
18" 
16-  •  (:95~B19 
o  v  (:gs~  L/'  1/  ,J  ' 
Q  14-  •  c95~ 
~  10- 
rr  6 
t- 
O 
<  4 
2- 
0  ....  i  ........  I  ........  I  ........  i  ........  I 
0.01  0.1  1  10  100 
agrin concentration [nM] 
Figure 4.  Dose response  curves  for AChR-aggregating  activity of 
95 kD,  COOH-terminal fragment of agrin isoforms.  Chick myo- 
tubes were incubated  for 16 h with recombinant agrin isoforms at 
the concentrations  indicated  and the number of AChR clusters  per 
myotube was determined  as described in Materials  and Methods. 
Area of the myotubes  is normalized.  Data points  represent  mean 
+  SEM of duplicate  cultures  with 10 myotube segments  counted 
in each. Dose response curves for each isoform show result of one 
representative  experiment.  No clustering activity was observed for 
C95AOB0, while  some AChR clusters  were  detected  at  64  nM  of 
C95A4a0. The curve was fit to data points by eye. Number of AChR 
clusters  without  agrin,  half-maximal  and  maximal  number  of 
clusters  are indicated  by dotted lines. 
formed  AChR aggregates,  which  are  smaller  in  size than 
those induced by agrin (Fig.  3; Godfrey et al.,  1984) were 
accounted for by excluding clusters in which the longer axis 
was less than 4 #m. As shown in Fig. 4, the most active iso- 
form  on  chick  myotubes  was  C95A,BS. Its  ECs0  (effective 
concentration  needed  to  induce  a  half-maximal  response) 
Figure  3.  AChR-aggregating 
activity  of  agrin  isoforms. 
Fluorescence micrographs of 
segments  of  cultured  chick 
myotubes labeled  with  rhoda- 
mine-a-bungarotoxin.  Only 
spontaneously  formed  AChR 
clusters were detected in myo- 
tubes  incubated for 16 h with 
conditioned  medium  of COS 
cells that had been transfected 
with the vector alone  (a)  and 
64  nM  of  affinity-purified 
C95AOBO (b).  Few  AChR  ag- 
gregates were seen after incu- 
bation  with 64 nM of C95A4B0 
(C).  In contrast,  active  agrin 
isoforms (d-h) induced the for- 
mation  of up to 20-fold more 
AChR aggregates than in con- 
trol  cultures.  Concentrations 
and agrin fragments used were 
64 nM c95^4B, (d),  1.6 nM C95A4m9 (e), and 400 pM of each C95A4e~ ff), cFuI1A4B8  (g),  and rl00A4m (h).  The sizes and shapes of AChR 
clusters induced by active agrin isoforms was independent of their composition at sites A and B (d-f), the size of agrin (g), and the species 
(h). Please note that spontaneous AChR aggregates in a and b are very frequent but are distinct from agrin-induced clusters by their smaller 
size. Bar, 40/~m. 
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Figure 5.  Comparison of AChR-aggrcgating activities of recom- 
binant agrin isoforms. (a) AChR aggregation  on primary chick myo- 
tubes induced by the COOH-terminal,  95 kD fragment,  and full- 
length chick agrinA4~ are very similar. (b) Dose response curves 
of COOH-terminal,  95 kD chick agrinA4~ and a similar fragment 
of ray agrin^4Bs show that both species homologues are similarly 
active. (c) Response of C2C12 myotubes to different chick agrin 
isoforms.  Because  agrin-induced  AChR aggregates are less  fre- 
quent,  but larger  than on chick myotubes, agrin's activity  is ex- 
pressed as percentage area of AChR clusters. C2C12 myotubes re- 
spond to agrin isoforms similarly as primary chick myotubes. At 
was 35  +  3 pM (mean +  SEM; N  =  4). The second most 
active isoform was  C95A4m9  with an ECso of 108  +  12 pM 
(mean  -I-  SEM;  N  =  3),  followed by  C95^4BH  with  5  -I- 
1 nM (mean -I- SEM; N =  3). No detectable activity was ob- 
served with C95A0~0 even at concentrations of 64 nM.  For 
c95^4Bo, we observed low levels of activity, but only at very 
high concentrations (64 nM).  Some AChR-aggregating ac- 
tivity of affinity-purified agrin-like proteins from nonneu- 
ronal tissue was observed by Godfrey (1991),  which may be 
based on the presence of this weakly active agrinA4Bo. 
To elucidate whether sequences in the NH2-terminal half 
of chick agrin may contribute to its AChR-aggregating activ- 
ity, we compared the dose response curves of the most active 
COOH-terminal  half,  C95A4SS, with  that  of cFullA4~.  As 
shown in Fig. 5 a, the two curves overlap almost perfectly. 
Like c95Ao~0, cFuI1AoB0 did not induce AChR aggregation at 
concentrations  of up to 4  nM  (4 nM of cFull~oBo: 2.31  + 
0.34 AChR clusters/10,000/~m2;  blank: 2.43  +  0.27 AChR 
clusters/10,000/xm2).  Thus, the presence of the NH2-termi- 
nal half of chick agrin has no effect on AChR aggregation on 
chick myotubes. 
Since  most previous experiments on AChR aggregation 
used agrin purified from the electric ray, we also compared 
the activity of recombinant ray and chick agrin. We gener- 
ated cDNA constructs encoding the COOH-terminal half of 
ray agrinA4BS and agrin^4Bo using cDNA clone OL4 (Smith et 
al., 1992). When tested on chick myotubes, the dose depen- 
dence of AChR clustering induced by rl00A4B8 waS similar 
to that of C95A4BS (Fig.  5  b).  As expected from the results 
using recombinant chick agrin, no activity was detected with 
4  nM  of rl00A4~0 (rl00A4S0:1.93  +  0.24  AChR  clusters/ 
10,000  /~m2; blank:  1.79  +  0.28  AChR  clusters/10,000 
/zm2). If we account for the systematic error in determining 
the  concentration  of ray  agrin  by  the  ELISA  (Table  I), 
rl00A4B8 is '~1.5 times less active than shown in Fig.  5  b. 
Nevertheless, these experiments show that homologous iso- 
forms of the marine ray and chick have similar activities. 
Activity of rat agrin isoforms depends on the myotubes on 
which they are tested. On primary rat myotubes and on the 
mouse C2C12 cell line, all rat agrin isoforms are active in 
aggregating AChRs (Ferns et al., 1992,  1993). On the other 
hand,  on  chick primary myotubes and  on variants of the 
C2C12 cell line that are defective in glycosaminoglycan syn- 
thesis, only isoforms containing amino acids at sites A and 
B are active (Ferns et al.,  1992,  1993).  Although the ECho 
of different agrin isoforms were not determined, semiquan- 
titative assays revealed that on the latter cells,  rat agrinA4Bs 
and  agrin^4Bt9 were  more  active  than  agrinA,8..  To  test 
whether the activity of chick agrin isoforms also depended 
on the myotubes, we determined the dose dependence of four 
agrin isoforms on myotubes formed by the C2C12 cell line 
400 pM of agrin^4Bs (C95A4BS) and agrinA4~19 (C95A4m9; cFulIA4sI9); 
and  at  64  nM  of C95A4B,, maximal  response  is  reached.  No 
cluster-inducing activity is observed for 400 pM of cFulIAoB0 and 
64 nM  of c95~Bo. Each data point represents mean  +  SEM  of 
duplicate cultures,  where  10  myotube segments were counted in 
each. AChR dusters without agrin are given (control). Area of  AChR 
clusters induced by c95~, C95A4BI9,  cFulIA4B19, and C95A4BII do not 
differ from each other (p > 0.1). Similarly, no significant difference 
to the control  is observed  in cultures treated  with cFuI1AoB0 and 
C95AOBO. 
Gesemann et al. Agrin-induced AChR Aggregation  631 (Yaffe and Saxel,  1977;  Blau et al.,  1983).  Since AChR ag- 
gregates on C2C12 myotubes were larger than those on chick 
myotubes (data not shown), the extent of AChR aggregation 
was  expressed  as  the  percentage  area  covered  by  AChR 
clusters.  The EC~0 of c95A4~ and C95^4a19 was  ,,o35 pM and 
that of c95^4B, was ,,ol00-fold lower (data not shown).  AS 
observed on chick myotubes, 400 pM of C95A4m,  C95A4~19, 
and cFull^4B19 induced  maximal response,  while  the  same 
concentration  of cFullAoB0 failed to  induce  AChR  clusters 
(Fig.  5  c).  Consistent  with  the  data  on  chick myotubes, 
C95AOB0 did  not  induce  detectable levels of AChR  clusters 
and  c95^4B,  reached  the  same  maximal  response  as  the 
other active agrin isoforms (Fig. 5 c). In summary, induction 
of AChR  aggregates on  C2C12  myotubes by recombinant 
chick agrin closely followed that on chick primary muscle 
ceils. 
A  Minimal Fragment with AChR-aggregating Activity 
In a  subsequent step we  investigated which  structural  do- 
mains of agrin confer its AChR-aggregating activity. As a re- 
sult of our studies on activities of agrin isoforms, we con- 
structed deletion mutants of the most potent agrin isoform 
agrinA4as and the inactive agrinA0ao. The end point of the de- 
letions was chosen to leave the different domains of agrin in- 
tact to promote proper folding of the recombinant protein. 
The first deletions started at amino acid 1487  of full-length 
chick agrin (Tsim et al.,  1992). They contained both sites A 
and B, two domains homologous to the G domain of laminin 
ix-chains,  and the last EGF-like repeat (c45;  Fig.  1).  The 
second deletions started at amino acid  1722  and contained 
the B-site and the last G domain (c21;  Fig.  1). As shown in 
Fig. 6, both mutants are secreted efficiently from transiently 
transfected COS cells.  The concentration of c45- and c21- 
proteins in the conditioned medium was assessed by immuno- 
precipitating metabolically labeled protein and comparing 
its  [35S] content  with  that  of C95A4B8 that  had  undergone 
identical treatment (Fig.  6).  The absolute concentration of 
C95A4B8  in  the  conditioned  medium  was  determined  by 
ELISA.  In two independent  experiments the  ratio of c95: 
c45:c21  was 1:20:30.  The increase in concentration for the 
small proteins c45 and c21  is expected and is an indication 
that  the  deletion  mutants  fold  correctly  and  thus  are  not 
degraded intracellularly. 
As shown in Fig. 7, the dose response curve of C45A4~ is 
slightly shifted compared to that of C95A4BS. In three inde- 
pendent  experiments,  ECs0 of C45A4B8 was  132  +  17  pM 
(mean  +  SEM;  N  =  3).  Hence, C45A4~8 is approximately 
fourfold less active than C95A4BS. AS observed for C95A0a0, 
no activity was detected in C45AOBO, even at concentrations 
of 100 nM. The smallest fragment, c21B8, was still capable 
of inducing AChR aggregation, with an ECs0 of 13  +  4 nM 
(mean +  SD; N  =  2). Its activity depended on the presence 
of amino acids  at the  B-site,  since  c21Bo failed to  induce 
AChR clustering (Fig.  7).  As was observed for agrin iso- 
forms that have different ECs0 values (Figs.  3  and 4),  the 
maximal number of AChR clusters was the same for both 
C45A4BS and c21Ba. Thus,  an agrin fragment containing the 
Bs-site  and  the  most  COOH-terminal  G  domain  (G3)  is 
Figure 6. Autoradiogram of recombinant deletion mutants c45 and 
c21 of agrin. COS-'/cells expressing agrin fragments were labeled 
with [35S]methionine, recombinant protein was immunoprecipated 
with  anti-agrin  antiserum  and  resolved  on  a  3-12%  SDS- 
polyacrylamide gel. Quantification of incorporated radioactivity by 
a Phosphorlmager  revealed that the average-ratio of concentration 
in  the  conditioned  medium  was  C95^4Bs:C45A4~0BS~0:C21a010  = 
1:20:30.  Migration  of standard  proteins  with  known  molecular 
weight are indicated. 
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Figure 7.  Dose  response  curves of deletion  mutants  of agrinA4~s 
and agrinA0a0. Chick primary myotubes were incubated for 16 h 
with the concentration of recombinant agrin indicated. As a refer- 
ence,  dose  response  curve  of C95A4BS is  also  shown. Each  data 
point represents result (mean + SEM) from duplicate myotube cul- 
tures,  10 segments counted in each. Data shown represent results 
of one representative experiment. Curves were fit to data points by 
eye. Number of AChR clusters  without agrin,  half-maximal and 
maximal number of clusters are indicated by dotted lines. 
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orders of magnitude higher, indicating that domain G2 and 
the last EGF-like repeat contribute to agrin's activity. 
Exogenous heparin  and other polyanions inhibit agrin- 
induced AChR aggregation (Wallace,  1990).  Furthermore, 
binding of agrin to a-dystroglycan is inhibited by heparin 
(Bowe  et al.,  1994;  Gee et al.,  1994;  Campanelli et al., 
1994; Sugiyama et al., 1994).  To test whether AChR aggre- 
gation induced by c45A4a8 and c21a8 could be inhibited by 
heparin, chick primary myotubes were incubated for 6 h with 
approximately four times the amount of recombinant agrin 
needed  to  induce  half-maximal  response.  While  AChR 
aggregation induced by c45^4a8 was inhibited by heparin, no 
inhibition was observed for AChR aggregation induced by 
c21as (Fig.  8 a).  These results indicate that heparin does 
not inhibit AChR aggregation per se. 
Since 100-fold higher concentrations of c21a8 are needed 
to induce the same number of AChR clusters as for C45A4U, 
we  tested  the  heparin-binding  properties  of c45A4~ and 
c21,8.  Conditioned medium of transfected COS cells was 
applied to heparin columns and the concentration of recom- 
binant agrin in the flowthrough and the eluate was deter- 
mined  by  immunoprecipitation.  In  agreement  with  the 
results on heparin-inhibition of AChR aggregation, c45^4a8 
bound to these columns and c21~ was detected in the flow- 
through (Fig.  8 b).  We also tested whether this treatment 
depleted  AChR-aggregating  activity  of  the  conditioned 
medium. Indeed, no AChR-aggregating activity was detected 
in c45A4as-containing medium after heparin column chro- 
matography, while activity in c21as-containing  medium was 
unchanged (data not shown). Thus, c21as has lost the capa- 
bility of binding heparin, Our results show that it neverthe- 
less retains AChR-aggregating activity, indicating that the 
binding  sites  for  heparin  and  for  activating  a  signal- 
transducing receptor are distinct from each other. The 100- 
fold higher EC50 of c21~ suggests  that the heparin-binding 
site in agrin may have an important auxiliary function in 
agrin-induced AChR aggregation. 
Discussion 
Role of  Agrin Isoforms in the Formation of the 
Neuromuscular Junction 
Our results show that agrinA4u and agrinA4a19 are most po- 
tent in inducing AChR aggregation. Early in the develop- 
ment  of the  chick,  the  most  abundant  agrin  mRNA  in 
cholinergic neurons, such as ciliary ganglia neurons and mo- 
tor neurons, codes for agrinA4al9 (McMahan et al.,  1992; 
Smith and O'Dowd, 1994; Ruegg, M. A., M. J. Werle, S. E. 
Horton, L. S.  Honig, and U. J.  McMahan, manuscript in 
preparation). Later, chick motor neurons express high levels 
of agrinA4aS (Honig, L. S., D. Stone, K. Nikolics, and U. J. 
McMahan. 1993. Soc. Neurosci. Abstr. 1272) and its relative 
abundance increases in chick ciliary ganglia (Thomas et al., 
1993) and rat spinal cord (Hoch et al.,  1993).  In addition, 
Figure 8. Inhibition of agrin-induced AChR aggregation by heparin and binding of agrin fragments to heparin columns. (a) 4 U (1 U = 
concentration of agrin inducing half-maximal response) of C45A4a8 or c21a8 were added to primary chick myotubes for 6 h in the presence 
of heparin at the indicated concentration. Data points represent mean :1: SEM of 10 myotube  segments. Heparin inhibits AChR  aggregation 
induced by C45A4B8 (p < 0.001), but not by c21Ba (p > 0.05). (b) Binding of agrin fragments to beparin columns. Conditioned medium 
of 35S-labeled COS cells that had been transfected with agrin constructs indicated were applied to heparin columns. Autoradiograms of 
3-12 % SDS-polyacrylamide  gels of immunoprecipitations  with anti-agrin antiserum. Different  sections are: conditioned medium (Cont.), 
flowthrough (Hep. -), and eluate of the heparin columns (Hep. +). Quantification  of the incorporated radioactivity under each condition 
shows that all C45A4a8 is depleted by heparin columns, while no c21B8 is retained. 
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which consists of gliai cells and motor neurons innervating 
the  electric  organ,  encodes  agrin^4~  (McMahan  et  al., 
1992).  Thus, it is feasible that cholinergic neurons early in 
development secrete high amounts of agrin^4Btg,  while at 
later  stages  and  throughout  adulthood,  they  synthesize 
agrin^4ss. Our results that both isoforms are highly active in 
inducing  AChR  aggregation  support  the  hypothesis  by 
McMahan (1990.) that agrin released by motor neurons in- 
duces the formation of synapses in the target cell. 
As previously shown (Ruegg  et al.,  1992),  agrin^4B, is 
active in inducing AChR aggregation. With the quantitative 
assay, we demonstrate here that its ECho is approximately 
two orders  of magnitude higher than that of agrin~Bs or 
agrin^4B~9. The expression of transcripts encoding agrinA4B~ 
in tissue containing cholinergic neurons, such as spinal cord 
and ciliary ganglia, peaks very early in neural development 
(Thomas et al., 1993; Hoch et al., 1993), before differentia- 
tion to neurons is complete. Precursor cells in the neural 
tube synthesize mainly agrinm~ and agrinA4BO  (McMahan et 
al.,  1992).  Thus, differentiation into neurons may alter the 
intrinsic splice machinery of the cell such that the 33 bp 
are inserted at the B-site giving rise to mRNA encoding 
agrin^4Bu. Subsequent modification of this path later in de- 
velopment may then include the 24-bp exon, leading to the 
expression of mRNA encoding agrin^413t9  and/or agrin^48~. 
Thus,  alteration of the  splicing  pattern  in  differentiating 
neurons would result in agrin isoforms that are active in in- 
ducing postsynaptic structures and agrin^4BH would be the 
first transient means to achieve this. 
In contrast to neurons, muscle cells express high levels of 
transcripts encoding agrinAoB0 (Ruegg et al.,  1992;  Hoch et 
ai.,  1993;  Ma et al.,  1994).  In agreement with previous 
reports  (Ruegg  et  al.,  1992),  we  find that  recombinant 
agrinA0so does not show any activity. From this we conclude 
that agrin isoforms secreted by muscle cells do not play a pri- 
mary role in clustering AChRs. This conclusion is strength- 
ened by findings of Reist et al.  (1992)  that agrin released 
from motor neurons and not from myotubes induces the for- 
marion of AChR clusters in vitro. Our conclusion would also 
be in agreement with many other studies in several  species 
showing  that  the  formation of neurotransmitter-receptor 
clusters in vivo depends on innervation (e.g.,  Frank and 
Fischbach,  1979;  Dahm and Landmesser,  1991; Liu and 
Westerfield, 1992;  Broadie and Bates,  1993). 
Differential Activities of Chick and Rat Agrin Isoforms 
The ability of agrin isoforms to induce AChR clusters has 
also been tested using rat cDNA clones (Ferns et al., 1992, 
1993).  With  COOH-terminal  fragments  of  agrin^4Bs, 
agrin^4Bo, and  agrinAoB0 that were  78  amino  acids  longer 
than chick c95-fragments, agrin^4Bg was  ~l,000-fold more 
potent  in  inducing  AChR clusters  on  C2  myotubes than 
agrinA4BO and no activity was detected for agrinA0~o (Ferns et 
al.,  1993).  Thus,  AChR-aggregating activity  of COOH- 
terminal fragments of rat and chick ^grin isoforms is qualita- 
tively similar although no direct comparison of  their dose de- 
pendence (ECs0) is possible. 
This  dependence  of AChR-aggregating activity on  the 
composition of agrin at sites A and B is not seen under cer- 
tain conditions (Ferns et al., 1992, 1993). COS cells that are 
transfected with full-length rat agrin expressed the protein on 
their cell surface (CampaneUi  et al., 1991). When tested in 
this cell-attached form, AChR aggregation on rat primary 
and on C2 myotubes was induced by all ^grin isoforms. On 
primary chick myotubes, only agrin^4Bs and agrin^4B19 were 
highly active,  while agrina4B, was moderately active and 
agrin^4a0 was inactive (Ferns et al.,  1992,  1993).  In an at- 
tempt to find reasons for such behavior of rat agrin, we have 
determined dose response curves for full-length chick ^grin 
and have tested some of the chick ^grin isoforms on C2 myo- 
tubes. Our findings show that the correlation between AChR- 
aggregating activity and the composition of agrin at sites A 
and B is influenced  by neither the size and the species (chick 
or ray) of agrin nor the origin of the myotubes (Fig. 5). Since 
we used soluble ^grin in all of our assays, we conclude that 
the presentation of rat agrin on the surface of transfected 
cells is most likely the reason for the different results. It re- 
mains to be seen whether phosphorylarion of the ~ subunit 
of AChRs observed after the addition of soluble agrin can 
also be triggered by high local concentrations of weakly ac- 
tive or inactive ^grin isoforms. 
Domains of  Agrin Involved in AChR Aggregation 
To obtain insights into the molecular mechanisms by which 
^grin induces AChR aggregation and to assess the role of 
structural domains of agrin in this process, we determined 
the  ECs0 of deletion  mutants  of agrin  to  induce  AChR 
clustering. Agrin fragments lacking the NH2-terminal  half, 
which contains domains that have been proposed to be of 
potential importance for agrin binding to basal lamina or to 
certain  differentiation  factors  (discussed  in  Patthy  and 
Nikolics,  1993),  show the same dose dependence as full- 
length agrin^4Bg (Fig.  5  a).  Thus, the 95-kD,  COOH-ter- 
minal fragment comprises all of the structural domains that 
contribute to agrin's AChR-aggregating activity.  Removing 
all the  domains except those that contain sites  A  and B 
resulted in the fragment c45^4Bs with ~4 times higher ECs0 
(Fig. 7). This indicates that either G1 and/or any of the three 
EGF-like repeats contribute to agrin's AChR-aggregaring  ac- 
tivity or that the folding of c45^4B8 is slightly altered. Dele- 
tion of G2, containing site A, and the last EGF-like repeat 
increased ECho by approximately two orders of magnitude 
(Fig. 7). Nevertheless, this recombinant fragment was capa- 
ble of inducing AChR aggregation to the same extent as the 
other fragments, indicating that the presence of site Bs to- 
gether with G3  is sufficient for this activity.  Our data on 
heparin binding of c21Bs and inhibition of AChR aggrega- 
tion by heparin suggest that the higher ECs0 of c21Bs may be 
due to the loss of the heparin-binding site rather than to the 
misfolding of the recombinant fragment (see below). We fur- 
ther tested activity of a cyclic peptide with the sequence of 
Bs  and a  linear Bs-peptide  that was  flanked by  l 1-amino 
acid long spacers.  Both  reagents neither induced nor in- 
hibited AChR aggregation (data not shown), demonstrating 
that the B insert alone is not sufficient for activity.  These 
results indicate that binding of ^grin to its signal-transducing 
receptor depends on the secondary structure of the ligand. 
Consequently, we hypothesize that amino acids of insert B 
may impose a certain structure on the G3 domain to expose 
the actual receptor-binding site. 
A similar approach to characterize the active site of rat 
agrin has been taken by Hoch et al. 0994).  Their smallest 
fragment capable of inducing AChR aggregation was larger 
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No activity was detected in a  fragment similar in size to 
C45A4B8 that also included G2, the last EGF-like repeat and 
G3.  In  contrast  to  C45A4BS, the  rat  fragment was  poorly 
secreted from COS cells. According to Hoch et al. (1994), 
the amount of the small fragment secreted by COS cells is 
only ~1/100 of that of their 95-kD fragment. In our experi- 
ments, COS cells secrete ,x,20 times more of C45A4BS than 
C95A4B8.  This *2,000-fold difference in secretion between 
similar constructs in rat and chick raises the possibility that 
the small agrin fragment in rat may not be folded correctly 
and hence be degraded, which would explain the failure to 
detect activity. Similarly, no activity was detected for rat 
constructs that contained the last EGF-like repeat and the G3 
domain. Because Hoch et al. (1994) did not provide data on 
the concentrations of agrin fragments that were tested in the 
AChR aggregation assay, it is impossible to assess whether 
their experimental conditions would have allowed detection 
of activity of fragments with high ECs0 values. 
Possible Mechanisms of  Agrin-induced 
AChR Aggregation 
AChR aggregation induced by agrin isolated from the elec- 
tric organ of Torpedo californica  is inhibited by heparin and 
several  other polyanions (Wallace,  1990).  The main frag- 
ment of active agrin found in such extracts has a Mr of 95 
kD.  We show that a  45  kD,  COOH-terminal fragment of 
agrinA4BS still binds to heparin, indicating that domains G2, 
the fourth EGF-like repeat,  and G3  are  sufficient for this 
binding.  Since  the  agrin  fragment  c21Bs has  lost  this 
heparin-binding site, domains G2 and/or the fourth EGF-like 
repeat  are  required  for  heparin-binding.  In  laminin,  the 
heparin-binding site has been mapped to the elastase frag- 
ment E3, which consists of the last two G domains of the ter- 
minal globule of the or-chains (Ott et al.,  1982;  Skubitz et 
al., 1988, 1991). In analogy, we suggest that the G2 domain 
and not the fourth EGF-like repeat of agrin is required to 
bind heparin. 
Heparin bound to agrin could either interfere with sites 
that  are  necessary  for  agrin  to  interact  with  its  signal- 
transducing receptor, or prevent binding of agrin to mole- 
cules supporting its AChR-aggregating activity.  Our finding 
that  the  ECso of c21Bs  is  ~100-fold  higher  than  that  of 
c45A4as suggests  the  latter  possibility to  be  more  likely. 
Since heparan sulfate also inhibits agrin- and nerve-induced 
AChR aggregation (Hirano and Kidokoro,  1989;  Wallace, 
1990), heparan sulfate proteoglycans that accumulate at both 
nerve- and agrin-induced AChR aggregates (Anderson and 
Fambrough,  1983;  Wallace,  1989)  are possible candidates 
for proteins that may bind agrin. 
Another candidate is the recently identified c~-dystrogly- 
can,  a  peripheral  membrane  protein  of the  dystrophin- 
glycoprotein complex. A 100 kD, COOH-terminal fragment 
of rat agrin binds to c~-dystroglycan  with high affinity and 
its binding is inhibited by laminin and by low concentrations 
of heparin  (Campanelli  et  al.,  1994;  Gee  et  al.,  1994; 
Sugiyama et al., 1994). Likewise, laminin binding to a-dys- 
troglycan is  inhibited by heparin  (Ervasti and Campbell, 
1993). The c~-dystroglycan-binding site in laminin has been 
mapped to fragment E3 and it has been suggested that do- 
mains responsible for binding to heparin and c~-dystroglycan 
are identical (Gee et al.,  1993).  We show that in agrin the 
G2 domain and/or the last EGF-like repeat are required for 
heparin-binding and we also propose that the binding sites 
for heparin and ot-dystroglycan overlap. 
The following observation supports this hypothesis. Agrin 
purified from electric organ of Torpedo  consists of two major 
proteolytic fragments (Mr 95 kD and 70 kD) with identical 
NH2-terminal  sequences (Nitkin et al.,  1987; Smith et al., 
1992). The 70-kD fragment probably still contains domain 
G2, but lacks the last EGF-like repeat and G3. Confirming 
our results that G3 is required for AChR aggregation, the 70 
kD fragment is inactive (Nitkin et al., 1987),  but neverthe- 
less it still binds to tx-dystroglycan (Ma et al.,  1993). 
If c21B8 lacks  the  binding  site  to  tx-dystroglycan, the 
100-fold higher ECs0 of this fragment compared to C45A4B8 
suggests  that ot-dystroglycan serves as a helper protein to 
augment agrin's AChR-aggregating activity. Our data on the 
binding of heparin and its inhibitory effect on AChR aggrega- 
tion indicate that the so far described binding of agrin to 
a-dystroglycan is not an absolute requisite for agrin to exert 
its AChR-aggregating activity. On the other hand, other com- 
ponents of the dystrophin-glycoprotein complex may serve 
as the signal-transducing receptor. Indeed, the findings that 
components of  the dystrophin-glycoprotein  complex are con- 
centrated at agrin-induced AChR clusters  in  vitro  (Cam- 
panelli et al., 1994; Gee et al., 1994; Sugiyama et al., 1994) 
as well as at the NMJ (Ohlendieck et al., 1991) suggest that 
they may contribute to the formation of postsynaptic struc- 
tures.  The  possibility  that  a-dystroglycan may  serve  as 
helper protein for agrin's AChR-aggregating activity would 
fit well with findings for other differentiation factors, such 
as transforming growth factor-/3 (L6pez-Casillas et al., 1991, 
1993; Wang et al., 1991) and basic fibroblast growth factor 
(Rapraeger et al.,  1991) where proteoglycans serve as cell 
surface receptors to present the ligands to their signaling 
receptors. 
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